Showing results (51-60 of 251) with videos related to
Sort By:
Pageof 26
Acta Gastro-Enterologica Belgica|October 23, 2020
Appendiceal cancer : a review of the literatureM Van de Moortele, G De Hertogh, X Sagaert, et al.Journal of Clinical Gastroenterology|December 1, 1988
Estrogen-progesterone treatment of Osler-Weber-Rendu diseaseE Van Cutsem, P Rutgeerts, K Geboes, et al.Acta Gastro-Enterologica Belgica|November 23, 2011
Familial adenomatous polyposis: clinical presentation, detection and surveillanceS Laurent, D Franchimont, J P Coppens, et al.Gut|April 16, 1998
Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptyingA Wilmer, E Van Cutsem, A Andrioli, et al.Acta Clinica Belgica|March 21, 2008
Cost-effectiveness of cetuximab in combination with irinotecan compared with current care in metastatic colorectal cancer after failure on irinotecan--a Belgian analysisL Annemans, E Van Cutsem, Y Humblet, et al.Hepato-Gastroenterology|June 17, 1999
The medical treatment of colorectal cancer: actual status and new developmentsE Van Cutsem, M Peeters, C Verslype, et al.Medical & Biological Engineering & Computing|September 1, 1989
Observation of the propagation direction of human electrogastric activity from cutaneous recordingsJ Chen, J Vandewalle, W Sansen, et al.European Radiology|August 25, 1999
Transcatheter embolization of hepatic arteriovenous fistulas in Rendu-Osler-Weber disease: a case report and review of the literatureL Stockx, H Raat, B Caerts, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panelM L Rothenberg, N J Meropol, E A Poplin, et al.Anti-Cancer Drugs|January 12, 2000
Clinical advances with topoisomerase I inhibitors in gastrointestinal malignanciesJ P Armand, D Cunningham, E van Cutsem, et al.Pageof 26